{"id":33838,"date":"2026-07-09T21:30:00","date_gmt":"2026-07-09T19:30:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=dda4222daa973ea4f02e713166e28214"},"modified":"2026-07-09T21:30:00","modified_gmt":"2026-07-09T19:30:00","slug":"universal-orthodontic-lab-appoints-dr-ryo-hamanaka-dds-phd-as-chief-clinical-officer-and-head-of-experimental-applications-group","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=33838","title":{"rendered":"Universal Orthodontic Lab Appoints Dr. Ryo Hamanaka, DDS, PhD as Chief Clinical Officer and Head of Experimental Applications Group"},"content":{"rendered":"

NORWALK, Calif.--(BUSINESS WIRE)--Universal Orthodontic Lab<\/a>, a leading orthodontic laboratory headquartered in Norwalk, California, today announced the appointment of Dr. Ryo Hamanaka<\/b>, a renowned orthodontic clinician and professor, as Chief Clinical Officer<\/b> and Head of the Experimental Applications Group<\/b>.<\/p><\/a><\/a>

\nDr. Hamanaka brings decades of clinical expertise and academic leadership in orthodontics. Widely recognized for advancing orthodontic education and treatment methodologies, he will lead clinical strategy while directing the Experimental Applications Group\u2014an internal initiative focused on developing and validating next-generation orthodontic solutions.<\/p>

\nIn this dual role, Dr. Hamanaka will bridge real-world clinical practice with cutting-edge dental laboratory applications, collaborating closely with doctors, scientists, and industry partners. His leadership is expected to accelerate clinical validation, improve patient outcomes, and drive innovation across the company's product and service portfolio.<\/p>

\n\"Dr. Hamanaka represents the rare combination of world-class clinician, educator, and innovator,\" said Joseph Kim, CEO of Universal Lab. \"As orthodontics evolves, laboratories must be led by individuals who understand both the science and the day-to-day realities of patient care. His appointment reflects our commitment to leading the industry at the intersection of clinical rigor and experimental discovery.\"<\/p>

\nDr. Hamanaka has held academic appointments as a professor of orthodontics at Nagasaki University and is internationally recognized for his clinical insight, mentorship, and commitment to advancing the field. His appointment reflects Universal Lab\u2019s ongoing investment in clinical excellence, education, and experimental development.<\/p>

\n\u201cI\u2019m excited to join Universal Lab at a time when technology, clinical insight, and innovation are converging,\u201d said Dr. Hamanaka. \u201cThe opportunity to lead clinical strategy while exploring novel applications and predictable delivery of care allows us to rethink what\u2019s possible for orthodontists and, ultimately, for patients.\u201d<\/p>

\nAbout Universal Orthodontic Lab<\/b><\/p>

\nUniversal Orthodontic Lab is a full-service orthodontic laboratory headquartered in Norwalk, California, dedicated to delivering high-quality, clinically driven orthodontic solutions since 1985. By combining advanced technology, experienced craftsmanship, and close collaboration with orthodontic professionals, Universal Lab supports practices in achieving predictable, efficient, and patient-centered outcomes.<\/p> Contacts<\/b>

\nMedia Contact:<\/b>press@uniortholab.com<\/a>562-484-0500<\/p>","protected":false},"excerpt":{"rendered":"

NORWALK, Calif.–(BUSINESS WIRE)–Universal Orthodontic Lab, a leading orthodontic laboratory headquartered in Norwalk, California, today announced the appointment of Dr. Ryo Hamanaka, a renowned orthodontic clinician and professor, as Chief Clinical O…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-33838","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/33838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=33838"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/33838\/revisions"}],"predecessor-version":[{"id":33841,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/33838\/revisions\/33841"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=33838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=33838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=33838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}